Novugen
FDA Approved Drugs
Novugen
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 16
- Latest Approval Date Oct 30, 2025
- Data Source FDA
- First Approval Date Jan 05, 2022
Company Overview
Social Profiles
Company Snapshot
Novugen
Unit 3301, 33rd Floor, Jumeirah Business Center 4, Cluster N, Jumeirah Lakes Towers, P.O. Box 392069, Dubai
U.A.E
www.novugen.com/index2.html pharmainfo@novugen.com View on MapFDA Approved Drug Records ( 16 records )
Drug Name
ABIRATERONE ACETATE
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2022-01-05
Active Ingredient
ABIRATERONE ACETATE
Application Number
215947
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2022-01-05
Regulatory Status
RX
Drug Name
ABIRATERONE ACETATE
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2022-01-05
Active Ingredient
ABIRATERONE ACETATE
Application Number
215947
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2022-01-05
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2025-10-30
Active Ingredient
EVEROLIMUS
Application Number
219955
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2025-10-30
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2025-10-30
Active Ingredient
EVEROLIMUS
Application Number
219955
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2025-10-30
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2025-10-30
Active Ingredient
EVEROLIMUS
Application Number
219955
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2025-10-30
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2025-10-30
Active Ingredient
EVEROLIMUS
Application Number
219955
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2025-10-30
Regulatory Status
RX
Drug Name
LENALIDOMIDE
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2024-09-11
Active Ingredient
LENALIDOMIDE
Application Number
217281
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2024-09-11
Regulatory Status
RX
Drug Name
LENALIDOMIDE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2024-09-11
Active Ingredient
LENALIDOMIDE
Application Number
217281
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2024-09-11
Regulatory Status
RX
Drug Name
LENALIDOMIDE
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2024-09-11
Active Ingredient
LENALIDOMIDE
Application Number
217281
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2024-09-11
Regulatory Status
RX
Drug Name
LENALIDOMIDE
Product Number
4
Dosage Form
-
Strength
15MG
Approval Date
2024-09-11
Active Ingredient
LENALIDOMIDE
Application Number
217281
Product Number
4
Dosage Form
-
Strength
15MG
Approval Date
2024-09-11
Regulatory Status
RX
Drug Name
LENALIDOMIDE
Product Number
5
Dosage Form
-
Strength
20MG
Approval Date
2024-09-11
Active Ingredient
LENALIDOMIDE
Application Number
217281
Product Number
5
Dosage Form
-
Strength
20MG
Approval Date
2024-09-11
Regulatory Status
RX
Drug Name
LENALIDOMIDE
Product Number
6
Dosage Form
-
Strength
25MG
Approval Date
2024-09-11
Active Ingredient
LENALIDOMIDE
Application Number
217281
Product Number
6
Dosage Form
-
Strength
25MG
Approval Date
2024-09-11
Regulatory Status
RX
Drug Name
MIDODRINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2023-10-17
Active Ingredient
MIDODRINE HYDROCHLORIDE
Application Number
211973
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2023-10-17
Regulatory Status
RX
Drug Name
MIDODRINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2023-10-17
Active Ingredient
MIDODRINE HYDROCHLORIDE
Application Number
211973
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2023-10-17
Regulatory Status
RX
Drug Name
MIDODRINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2023-10-17
Active Ingredient
MIDODRINE HYDROCHLORIDE
Application Number
211973
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2023-10-17
Regulatory Status
RX
Drug Name
PAZOPANIB HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE
Approval Date
2024-04-23
Active Ingredient
PAZOPANIB HYDROCHLORIDE
Application Number
218231
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE
Approval Date
2024-04-23
Regulatory Status
RX
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
16 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
16 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ABIRATERONE ACETATE
Application Number
215947
Product Number
1
Active Ingredient
ABIRATERONE ACETATE
Dosage Form
-
Strength
250MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.